Trial intelligence / Profile preview

Iron Therapy in Patients With End-Stage Renal Disease

NCT04491916Unknown

Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start
Apr 2020
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of iron sucrose in anemia, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoints: Mortality at 2 years, Coronary Artery Disease at 2 years and 1 more. Status: unknown.

02

Drugs

iron sucrose
03

Conditions

anemia

Beyond the preview

Go deeper on NCT04491916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04491916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call